Aspira Pathlab Proposes ₹65 Cr Rights Issue

Aspira Pathlab & Diagnostics Ltd announced its Board of Directors has approved a proposal to raise up to ₹65 crore through a Rights Issue. The funds will be raised from eligible equity shareholders, with the exact terms like issue price and ratio to be decided by a newly constituted Rights Issue Committee. This committee will also determine the record date and appoint necessary intermediaries. The Rights Issue, which can be in the form of equity or convertible instruments, is subject to shareholder and regulatory approvals.